(Q37756176)

22 August 2017

1 reference

title

Are adolescents dying by suicide taking SSRI antidepressants? A review of observational studies (English)

1 reference

22 August 2017

0 references

1 reference

3

Dusan Hadzi-Pavlovic

1 reference

22 August 2017

Michael Dudley

1

1 reference

22 August 2017

Robert Goldney

series ordinal

2

1 reference

22 August 2017

publication date

1 June 2010

1 reference

22 August 2017

published in

Australasian Psychiatry

1 reference

22 August 2017

volume

18

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

242-245

1 reference

Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Suicidality in pediatric patients treated with antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Persisting decline in depression treatment after FDA warnings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Do antidepressants cause suicidality in children? A Bayesian meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

New-generation antidepressants, suicide and depressed adolescents: how should clinicians respond to changing evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Authors of TADS study reply to letter raising concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Anti-depressants, suicide, and drug regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Do antidepressants precipitate youth suicide?: a nationwide pharmacoepidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Proper studies of selective serotonin reuptake inhibitors are needed for youth with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Antidepressants and the risk of suicidal behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Utah youth suicide study: psychological autopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Psychiatric Diagnosis in Child and Adolescent Suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Risk factors for suicide and attempted suicide among young people

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Suicide risk during antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10398561003681319

10.3109/10398561003681319

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference